Global Lyme Disease Vaccine Market Growth 2025-2031

January 2025 | 79 pages | ID: GFD4745E24A4EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Lyme Disease Vaccine market size is predicted to grow from US$ 486 million in 2025 to US$ 820 million in 2031; it is expected to grow at a CAGR of 9.1% from 2025 to 2031.

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the “Lyme Disease Vaccine Industry Forecast” looks at past sales and reviews total world Lyme Disease Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Lyme Disease Vaccine sales for 2025 through 2031. With Lyme Disease Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lyme Disease Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Lyme Disease Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lyme Disease Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lyme Disease Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lyme Disease Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lyme Disease Vaccine.

This report presents a comprehensive overview, market shares, and growth opportunities of Lyme Disease Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Inactivated Vaccine
• Attenuated Vaccine

Segmentation by Application:

• Hospital
• Scientific Research
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Merck
• Merial
• Zoetis

Key Questions Addressed in this Report

What is the 10-year outlook for the global Lyme Disease Vaccine market?

What factors are driving Lyme Disease Vaccine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Lyme Disease Vaccine market opportunities vary by end market size?

How does Lyme Disease Vaccine break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Lyme Disease Vaccine Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Lyme Disease Vaccine by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Lyme Disease Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Lyme Disease Vaccine Segment by Type
  2.2.1 Inactivated Vaccine
  2.2.2 Attenuated Vaccine
2.3 Lyme Disease Vaccine Sales by Type
  2.3.1 Global Lyme Disease Vaccine Sales Market Share by Type (2020-2025)
  2.3.2 Global Lyme Disease Vaccine Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Lyme Disease Vaccine Sale Price by Type (2020-2025)
2.4 Lyme Disease Vaccine Segment by Application
  2.4.1 Hospital
  2.4.2 Scientific Research
  2.4.3 Others
2.5 Lyme Disease Vaccine Sales by Application
  2.5.1 Global Lyme Disease Vaccine Sale Market Share by Application (2020-2025)
  2.5.2 Global Lyme Disease Vaccine Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Lyme Disease Vaccine Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Lyme Disease Vaccine Breakdown Data by Company
  3.1.1 Global Lyme Disease Vaccine Annual Sales by Company (2020-2025)
  3.1.2 Global Lyme Disease Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Lyme Disease Vaccine Annual Revenue by Company (2020-2025)
  3.2.1 Global Lyme Disease Vaccine Revenue by Company (2020-2025)
  3.2.2 Global Lyme Disease Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Lyme Disease Vaccine Sale Price by Company
3.4 Key Manufacturers Lyme Disease Vaccine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Lyme Disease Vaccine Product Location Distribution
  3.4.2 Players Lyme Disease Vaccine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR LYME DISEASE VACCINE BY GEOGRAPHIC REGION

4.1 World Historic Lyme Disease Vaccine Market Size by Geographic Region (2020-2025)
  4.1.1 Global Lyme Disease Vaccine Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Lyme Disease Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Lyme Disease Vaccine Market Size by Country/Region (2020-2025)
  4.2.1 Global Lyme Disease Vaccine Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Lyme Disease Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Lyme Disease Vaccine Sales Growth
4.4 APAC Lyme Disease Vaccine Sales Growth
4.5 Europe Lyme Disease Vaccine Sales Growth
4.6 Middle East & Africa Lyme Disease Vaccine Sales Growth

5 AMERICAS

5.1 Americas Lyme Disease Vaccine Sales by Country
  5.1.1 Americas Lyme Disease Vaccine Sales by Country (2020-2025)
  5.1.2 Americas Lyme Disease Vaccine Revenue by Country (2020-2025)
5.2 Americas Lyme Disease Vaccine Sales by Type (2020-2025)
5.3 Americas Lyme Disease Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Lyme Disease Vaccine Sales by Region
  6.1.1 APAC Lyme Disease Vaccine Sales by Region (2020-2025)
  6.1.2 APAC Lyme Disease Vaccine Revenue by Region (2020-2025)
6.2 APAC Lyme Disease Vaccine Sales by Type (2020-2025)
6.3 APAC Lyme Disease Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Lyme Disease Vaccine by Country
  7.1.1 Europe Lyme Disease Vaccine Sales by Country (2020-2025)
  7.1.2 Europe Lyme Disease Vaccine Revenue by Country (2020-2025)
7.2 Europe Lyme Disease Vaccine Sales by Type (2020-2025)
7.3 Europe Lyme Disease Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Lyme Disease Vaccine by Country
  8.1.1 Middle East & Africa Lyme Disease Vaccine Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Lyme Disease Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Lyme Disease Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Lyme Disease Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lyme Disease Vaccine
10.3 Manufacturing Process Analysis of Lyme Disease Vaccine
10.4 Industry Chain Structure of Lyme Disease Vaccine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Lyme Disease Vaccine Distributors
11.3 Lyme Disease Vaccine Customer

12 WORLD FORECAST REVIEW FOR LYME DISEASE VACCINE BY GEOGRAPHIC REGION

12.1 Global Lyme Disease Vaccine Market Size Forecast by Region
  12.1.1 Global Lyme Disease Vaccine Forecast by Region (2026-2031)
  12.1.2 Global Lyme Disease Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Lyme Disease Vaccine Forecast by Type (2026-2031)
12.7 Global Lyme Disease Vaccine Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Merck
  13.1.1 Merck Company Information
  13.1.2 Merck Lyme Disease Vaccine Product Portfolios and Specifications
  13.1.3 Merck Lyme Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Merck Main Business Overview
  13.1.5 Merck Latest Developments
13.2 Merial
  13.2.1 Merial Company Information
  13.2.2 Merial Lyme Disease Vaccine Product Portfolios and Specifications
  13.2.3 Merial Lyme Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Merial Main Business Overview
  13.2.5 Merial Latest Developments
13.3 Zoetis
  13.3.1 Zoetis Company Information
  13.3.2 Zoetis Lyme Disease Vaccine Product Portfolios and Specifications
  13.3.3 Zoetis Lyme Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Zoetis Main Business Overview
  13.3.5 Zoetis Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Lyme Disease Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Lyme Disease Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Inactivated Vaccine
Table 4. Major Players of Attenuated Vaccine
Table 5. Global Lyme Disease Vaccine Sales byType (2020-2025) & (K Units)
Table 6. Global Lyme Disease Vaccine Sales Market Share byType (2020-2025)
Table 7. Global Lyme Disease Vaccine Revenue byType (2020-2025) & ($ million)
Table 8. Global Lyme Disease Vaccine Revenue Market Share byType (2020-2025)
Table 9. Global Lyme Disease Vaccine Sale Price byType (2020-2025) & (USD/Unit)
Table 10. Global Lyme Disease Vaccine Sale by Application (2020-2025) & (K Units)
Table 11. Global Lyme Disease Vaccine Sale Market Share by Application (2020-2025)
Table 12. Global Lyme Disease Vaccine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Lyme Disease Vaccine Revenue Market Share by Application (2020-2025)
Table 14. Global Lyme Disease Vaccine Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Lyme Disease Vaccine Sales by Company (2020-2025) & (K Units)
Table 16. Global Lyme Disease Vaccine Sales Market Share by Company (2020-2025)
Table 17. Global Lyme Disease Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Lyme Disease Vaccine Revenue Market Share by Company (2020-2025)
Table 19. Global Lyme Disease Vaccine Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Lyme Disease Vaccine Producing Area Distribution and Sales Area
Table 21. Players Lyme Disease Vaccine Products Offered
Table 22. Lyme Disease Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Lyme Disease Vaccine Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Lyme Disease Vaccine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Lyme Disease Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Lyme Disease Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Lyme Disease Vaccine Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Lyme Disease Vaccine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Lyme Disease Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Lyme Disease Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Lyme Disease Vaccine Sales by Country (2020-2025) & (K Units)
Table 34. Americas Lyme Disease Vaccine Sales Market Share by Country (2020-2025)
Table 35. Americas Lyme Disease Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Lyme Disease Vaccine Sales byType (2020-2025) & (K Units)
Table 37. Americas Lyme Disease Vaccine Sales by Application (2020-2025) & (K Units)
Table 38. APAC Lyme Disease Vaccine Sales by Region (2020-2025) & (K Units)
Table 39. APAC Lyme Disease Vaccine Sales Market Share by Region (2020-2025)
Table 40. APAC Lyme Disease Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Lyme Disease Vaccine Sales byType (2020-2025) & (K Units)
Table 42. APAC Lyme Disease Vaccine Sales by Application (2020-2025) & (K Units)
Table 43. Europe Lyme Disease Vaccine Sales by Country (2020-2025) & (K Units)
Table 44. Europe Lyme Disease Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Lyme Disease Vaccine Sales byType (2020-2025) & (K Units)
Table 46. Europe Lyme Disease Vaccine Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Lyme Disease Vaccine Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Lyme Disease Vaccine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Lyme Disease Vaccine Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa Lyme Disease Vaccine Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Lyme Disease Vaccine
Table 52. Key Market Challenges & Risks of Lyme Disease Vaccine
Table 53. Key IndustryTrends of Lyme Disease Vaccine
Table 54. Lyme Disease Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Lyme Disease Vaccine Distributors List
Table 57. Lyme Disease Vaccine Customer List
Table 58. Global Lyme Disease Vaccine SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global Lyme Disease Vaccine RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Lyme Disease Vaccine SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas Lyme Disease Vaccine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Lyme Disease Vaccine SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC Lyme Disease Vaccine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Lyme Disease Vaccine SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe Lyme Disease Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Lyme Disease Vaccine SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Lyme Disease Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Lyme Disease Vaccine SalesForecast byType (2026-2031) & (K Units)
Table 69. Global Lyme Disease Vaccine RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Lyme Disease Vaccine SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global Lyme Disease Vaccine RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Merck Basic Information, Lyme Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Lyme Disease Vaccine Product Portfolios and Specifications
Table 74. Merck Lyme Disease Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Merial Basic Information, Lyme Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Merial Lyme Disease Vaccine Product Portfolios and Specifications
Table 79. Merial Lyme Disease Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Merial Main Business
Table 81. Merial Latest Developments
Table 82. Zoetis Basic Information, Lyme Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Zoetis Lyme Disease Vaccine Product Portfolios and Specifications
Table 84. Zoetis Lyme Disease Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Zoetis Main Business
Table 86. Zoetis Latest Developments



LIST OFFIGURES

Figure 1. Picture of Lyme Disease Vaccine
Figure 2. Lyme Disease Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lyme Disease Vaccine Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Lyme Disease Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Lyme Disease Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Lyme Disease Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Lyme Disease Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Inactivated Vaccine
Figure 12. Product Picture of Attenuated Vaccine
Figure 13. Global Lyme Disease Vaccine Sales Market Share byType in 2025
Figure 14. Global Lyme Disease Vaccine Revenue Market Share byType (2020-2025)
Figure 15. Lyme Disease Vaccine Consumed in Hospital
Figure 16. Global Lyme Disease Vaccine Market: Hospital (2020-2025) & (K Units)
Figure 17. Lyme Disease Vaccine Consumed in Scientific Research
Figure 18. Global Lyme Disease Vaccine Market: Scientific Research (2020-2025) & (K Units)
Figure 19. Lyme Disease Vaccine Consumed in Others
Figure 20. Global Lyme Disease Vaccine Market: Others (2020-2025) & (K Units)
Figure 21. Global Lyme Disease Vaccine Sale Market Share by Application (2024)
Figure 22. Global Lyme Disease Vaccine Revenue Market Share by Application in 2025
Figure 23. Lyme Disease Vaccine Sales by Company in 2025 (K Units)
Figure 24. Global Lyme Disease Vaccine Sales Market Share by Company in 2025
Figure 25. Lyme Disease Vaccine Revenue by Company in 2025 ($ millions)
Figure 26. Global Lyme Disease Vaccine Revenue Market Share by Company in 2025
Figure 27. Global Lyme Disease Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Lyme Disease Vaccine Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Lyme Disease Vaccine Sales 2020-2025 (K Units)
Figure 30. Americas Lyme Disease Vaccine Revenue 2020-2025 ($ millions)
Figure 31. APAC Lyme Disease Vaccine Sales 2020-2025 (K Units)
Figure 32. APAC Lyme Disease Vaccine Revenue 2020-2025 ($ millions)
Figure 33. Europe Lyme Disease Vaccine Sales 2020-2025 (K Units)
Figure 34. Europe Lyme Disease Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Lyme Disease Vaccine Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Lyme Disease Vaccine Revenue 2020-2025 ($ millions)
Figure 37. Americas Lyme Disease Vaccine Sales Market Share by Country in 2025
Figure 38. Americas Lyme Disease Vaccine Revenue Market Share by Country (2020-2025)
Figure 39. Americas Lyme Disease Vaccine Sales Market Share byType (2020-2025)
Figure 40. Americas Lyme Disease Vaccine Sales Market Share by Application (2020-2025)
Figure 41. United States Lyme Disease Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Lyme Disease Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Lyme Disease Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Lyme Disease Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Lyme Disease Vaccine Sales Market Share by Region in 2025
Figure 46. APAC Lyme Disease Vaccine Revenue Market Share by Region (2020-2025)
Figure 47. APAC Lyme Disease Vaccine Sales Market Share byType (2020-2025)
Figure 48. APAC Lyme Disease Vaccine Sales Market Share by Application (2020-2025)
Figure 49. China Lyme Disease Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Lyme Disease Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Lyme Disease Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Lyme Disease Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. India Lyme Disease Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Lyme Disease Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Lyme Disease Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Lyme Disease Vaccine Sales Market Share by Country in 2025
Figure 57. Europe Lyme Disease Vaccine Revenue Market Share by Country (2020-2025)
Figure 58. Europe Lyme Disease Vaccine Sales Market Share byType (2020-2025)
Figure 59. Europe Lyme Disease Vaccine Sales Market Share by Application (2020-2025)
Figure 60. Germany Lyme Disease Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61.France Lyme Disease Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Lyme Disease Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Lyme Disease Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Lyme Disease Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Lyme Disease Vaccine Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Lyme Disease Vaccine Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Lyme Disease Vaccine Sales Market Share by Application (2020-2025)
Figure 68. Egypt Lyme Disease Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Lyme Disease Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Lyme Disease Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Lyme Disease Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Lyme Disease Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Lyme Disease Vaccine in 2025
Figure 74. Manufacturing Process Analysis of Lyme Disease Vaccine
Figure 75. Industry Chain Structure of Lyme Disease Vaccine
Figure 76. Channels of Distribution
Figure 77. Global Lyme Disease Vaccine Sales MarketForecast by Region (2026-2031)
Figure 78. Global Lyme Disease Vaccine Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Lyme Disease Vaccine Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Lyme Disease Vaccine Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Lyme Disease Vaccine Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Lyme Disease Vaccine Revenue Market ShareForecast by Application (2026-2031)